Identifying Clinicopathological Association of DNA Hypermethylation in Cancers Using CpG Island Microarrays
- 915 Downloads
Hypermethylation of promoter CpG islands has been associated with gene silencing in cancer. Increasingly, these CpG islands have potential clinical utility as molecular markers for cancer diagnosis. Here we describe a microarray-based technique, called differential methylation hybridization (DMH), for simultaneous screening of methylation alteration across thousands of CpG island loci in one tumor sample at a time. We also describe a second approach, called methylation target array (MTA), for detecting methylation alteration of a single CpG island locus across hundreds of tumor DNA samples. The DMH and MTA assays are complementary to each other in that DMH allows for rapid identification of multiple loci hypermethylated in tumor genomes while MTA can rapidly assess the utility of these loci as markers for clinical diagnosis. Furthermore, the use of clustering algorithms to analyze the array data of multiple CpG island loci can identify an association of DNA hypermethylation with specific clinicopathological features of tumors.
KeywordsPromoter Hypermethylation Methylation Profile Restriction Landmark Genomic Scanning Differential Methylation Hybridization Concurrent Methylation
Unable to display preview. Download preview PDF.
- 11.Sanchez-Cespedes M, Esteller M, Wu L et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2001; 60:892–5.Google Scholar
- 32.DNA Methylation Protocols. Mills KI, Ransahoye BH, eds. Totowa: Humana Press, 2002.Google Scholar
- 34.Chen C-M, Chen H-L, Yan PS et al. Methylation “tissue” array: a novel technique for simultaneous analysis of extensive DNA hypermethylation in multiple breast tumors. Proc Am Asso Cancer Res 2002; 43:1124a.Google Scholar
- 41.Huang TH-M, Plass C, Liang G et al. Epi meets genomics: Technologies for finding and reading the 5th base. In: Beck & Olek, eds. The Epigenome—Molecular Seek and Hide. Verlag-VCH Verlag Gm5H, 2002 (submitted).Google Scholar
- 42.Yan PS, Perry MR, Laux DE et al. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer. Clin Cancer Res 2000; 1432:1432–1438.Google Scholar
- 45.Wei SH, Chen C-M, Strathdee G et al. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res 2002; in pess.Google Scholar
- 46.Yan PS, Efferth T, Chen H-L et al. Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods, in press.Google Scholar